Leading European researchers and clinicians have joined forces in a newly launched Network of Excellence (NoE) on finding new treatments for rare neuromuscular diseases (NMD), such as muscular dystrophies and spinal muscular atrophy.
Dubbed TREAT-NMD (Translational research in Europe - assessment and treatment of neuromuscular), the five-year network is the first of its kind in Europe, bringing together a total of 21 partner organisations from 11 countries. They include charities and companies that will work alongside doctors and researchers in the field.
HealthService24 Project validation pilots showed that the introduction of a mobile health monitoring service is not disruptive with current work practices. It can easily co-exist with other formats of service delivery, in some cases supplementing them or, in other cases, replacing previous practices. This facilitated the integration, putting the end-users in command to decide on the most adequate pace. 
Does eHealth contribute to saving lives?